Talk:20.109(F12) Pre-Proposal: Engineering Viral Magnetic Nanoparticles for Magnetic Hyperthermic Cancer Therapy: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
|||
| Line 25: | Line 25: | ||
:* High specific loss power (SLP) of the MNP. | :* High specific loss power (SLP) of the MNP. | ||
== Biomedical potentials of MNP == | == Biomedical potentials of MNP == | ||
== Current Work in MNP-M13 Bacteriophage Attachment == | |||
== What we propose to do == | == What we propose to do == | ||
== Potential Issues == | == Potential Issues == | ||
== Future Directions == | == Future Directions == | ||
== Useful Resources == | == Useful Resources == | ||
Revision as of 17:55, 28 November 2012
- This is a brainstorming page.
You are very welcome to write any crazy / non-crazy / inventive / conventional / knowledgeable ideas or information you may have about our project.
Some key words:
- Magnetic Nanoparticles (MNP)
- Viruses - M13 bacteriophage
- Magnetic Hyperthermia
- Bioengineering
What is Magnetic Hyperthermia?
Definition
Current Work
Current Limitations (This information will help us shape and define the problem.)
(1) To achieve the necessary rise in temperature with minimal dose of MNP.
- In other words, this means:
- High specific loss power (SLP) of the MNP.
